A microRNA, mir133b, suppresses melanopsin expression mediated by failure dopaminergic amacrine cells in RCS rats

Yaochen Li1, Chunshi Li, Zhongshan Chen

  • 1Southwest Hospital/Southwest Eye Hospital, Third Military Medical University, Chong Qing, China.

Cellular Signalling
|November 22, 2011
PubMed

Insights

MicroRNA 133b (mir133b) overexpression in retinal degeneration impairs dopaminergic amacrine cells, reducing melanopsin expression and visual signaling. This study reveals a novel mechanism affecting vision in retinal diseases.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Molecular Biology

Background:

  • Melanopsin-expressing retinal ganglion cells (mRGCs) are crucial for non-visual brain functions, but their expression decreases in retinal diseases.
  • The molecular mechanisms regulating melanopsin expression, particularly in disease states, remain poorly understood.
  • MicroRNAs are emerging as key regulators of neuronal development and cellular processes.

Purpose of the Study:

  • To investigate the molecular mechanisms controlling melanopsin expression in retinal degeneration.
  • To identify specific microRNAs involved in regulating melanopsin-containing retinal ganglion cells (mRGCs) during retinal disease progression.

Main Methods:

  • Utilized Royal College of Surgeon (RCS) rats as an animal model for retinal degeneration.
  • Employed quantitative real-time reverse transcription polymerase chain reaction to analyze microRNA expression.
  • Investigated the impact of mir133b on dopaminergic amacrine cells and mRGCs.

Main Results:

  • Identified mir133b as a microRNA significantly upregulated during early retinal degeneration in RCS rats.
  • Demonstrated that mir133b overexpression downregulates the transcription factor Pitx3 in dopaminergic amacrine cells.
  • Showed that mir133b impairs dopaminergic amacrine cell function, leading to reduced TH and dopamine production, ultimately decreasing melanopsin expression in mRGCs.

Conclusions:

  • Overexpression of mir133b and subsequent downregulation of Pitx3 suppress the maturation and function of retinal dopaminergic amacrine cells.
  • This disruption in dopaminergic amacrine cells leads to impaired mRGC dendrite stratification and reduced connections, resulting in decreased melanopsin expression.
  • The study highlights mir133b as a potential therapeutic target for preserving vision in retinal diseases characterized by melanopsin loss.